These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17976734)

  • 41. Evaluation of a manual ELISA kit for determination of HER2/neu in serum of breast cancer patients.
    Gauchez AS; Ravanel N; Villemain D; Brand FX; Pasquier D; Payan R; Mousseau M
    Anticancer Res; 2008; 28(5B):3067-73. PubMed ID: 19031958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
    Lu JQ; Fan Y; Mitha AP; Bell R; Metz L; Moore GR; Yong VW
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):179-89. PubMed ID: 19151622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid.
    Kakuda K; Ikenaka K; Araki K; So M; Aguirre C; Kajiyama Y; Konaka K; Noi K; Baba K; Tsuda H; Nagano S; Ohmichi T; Nagai Y; Tokuda T; El-Agnaf OMA; Ogi H; Goto Y; Mochizuki H
    Sci Rep; 2019 Apr; 9(1):6001. PubMed ID: 30979935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.
    Wu G; Yan B; Wang X; Feng X; Zhang A; Xu X; Dong H
    J Neurol Sci; 2008 Aug; 271(1-2):168-73. PubMed ID: 18495164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of an ELISA for the quantification of pig major acute phase protein (Pig-MAP).
    Piñeiro M; Lampreave F; Alava MA
    Vet Immunol Immunopathol; 2009 Feb; 127(3-4):228-34. PubMed ID: 19059652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of low-picomolar concentrations of TNF-alpha in serum using the dual-network microfluidic ELISA platform.
    Herrmann M; Veres T; Tabrizian M
    Anal Chem; 2008 Jul; 80(13):5160-7. PubMed ID: 18473486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
    Sass MB; Lorenz AN; Green RL; Coleman RA
    J Neurosci Methods; 2009 Apr; 178(2):366-77. PubMed ID: 19136028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid.
    Miners JS; Verbeek MM; Rikkert MO; Kehoe PG; Love S
    J Neurosci Methods; 2008 Jan; 167(2):229-36. PubMed ID: 17904641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-synuclein levels in patients with multiple system atrophy: a meta-analysis.
    Yang F; Li WJ; Huang XS
    Int J Neurosci; 2018 May; 128(5):477-486. PubMed ID: 29053035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Construction of urinary Tamm-Horsfall protein assay by enzyme-linked immunosorbent assay and establishment of reference range of healthy subject].
    Nishimaki J; Masuda M; Katoh S; Nakajima T; Kanamori K; Shimomura H; Shiba K
    Rinsho Byori; 2008 Oct; 56(10):862-7. PubMed ID: 19068782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microtiter plate-based determination of multiple concentration-inhibition relationships.
    Nelson AN; Lipsky JJ
    Anal Biochem; 1995 Nov; 231(2):437-9. PubMed ID: 8594997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein.
    Barkovits K; Kruse N; Linden A; Tönges L; Pfeiffer K; Mollenhauer B; Marcus K
    Cells; 2020 Feb; 9(2):. PubMed ID: 32033488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of cerebrospinal fluid drainage for providing a surgical approach in intracranial operations].
    Stolkarts IZ
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (2):61-2. PubMed ID: 3389017
    [No Abstract]   [Full Text] [Related]  

  • 58. Cerebrospinal fluid α-synuclein levels in Parkinson's disease--changed or unchanged?
    Zetterberg H; Petzold M; Magdalinou N
    Eur J Neurol; 2014 Mar; 21(3):365-7. PubMed ID: 24330157
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population.
    Wang SR; Chen ML; Huang MH; Lin HY; Tsai JJ; Kuo BI
    Clin Biochem; 1993 Dec; 26(6):455-60. PubMed ID: 8124860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ubiquitin in cerebrospinal fluid: a rapid competitive enzyme-linked immunoflow assay.
    Kudo T; Iqbal K; Ravid R; Swaab DF; Grundke-Iqbal I
    Neuroreport; 1994 Jul; 5(12):1522-4. PubMed ID: 7948853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.